We are live on ! Find out more
VAXX

Vaxxinity, Inc. Class A Common Stock
VAXX

Delisted

VAXX was delisted on the 8th of May, 2024.

Back to rankings

17 hedge funds and large institutions have $102M invested in Vaxxinity, Inc. Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+17
Holders Change %
–
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.4M
2
SM
Scoggin Management
New York
+$2.91M
3
Goldman Sachs
Goldman Sachs
New York
+$2.29M
4
Millennium Management
Millennium Management
New York
+$900K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$704K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PML
1
Prime Movers Lab
Wyoming
$91M +$186M +18,027,314 New
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$5.62M +$10.4M +1,001,670 New
SM
3
Scoggin Management
New York
$1.58M +$2.91M +281,169 New
Goldman Sachs
4
Goldman Sachs
New York
$1.24M +$2.29M +221,100 New
Millennium Management
5
Millennium Management
New York
$489K +$900K +87,083 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$382K +$704K +68,096 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$337K +$620K +60,000 New
HF
8
HRT Financial
New York
$286K +$527K +51,014 New
EMG
9
ETF Managers Group
New Jersey
$211K +$392K +37,884 New
DFCM
10
Dark Forest Capital Management
Puerto Rico
$101K +$187K +18,076 New
CCM
11
CAAS Capital Management
New York
$94K +$173K +16,771 New
VF
12
Virtu Financial
New York
$93K +$171K +16,566 New
Morgan Stanley
13
Morgan Stanley
New York
$63K +$116K +11,202 New
FIA
14
FNY Investment Advisers
New York
$27K +$50.1K +4,847 New
UBS Group
15
UBS Group
Switzerland
$14K +$26.5K +2,566 New
SSB
16
Sandy Spring Bank
Maryland
$1K +$1.03K +100 New
Bank of America
17
Bank of America
North Carolina
$1K +$2.07K +200 New

VAXX Hedge Fund Activity: Q4 2021 in Review

17 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q4 2021, worth a combined $102M.

Buyers outnumbered sellers: 17 funds opened new VAXX positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $10.4M.

  • 17 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $102M of Vaxxinity, Inc. Class A Common Stock stock for Q4 2021.
  • 17 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q4 2021 and 0 closed out, a net change of +17 holders.
  • The largest Vaxxinity, Inc. Class A Common Stock buyer in Q4 2021 was Adage Capital Partners, an estimated $10.4M added.

Based on aggregated 13F filings for Q4 2021.